Mosunetuzumab, CAS [[1905409-39-3]]

Produktübersicht

• Artikelname: Mosunetuzumab, CAS [[1905409-39-3]]
• Artikelnummer: MCE-HY-P99033
• Hersteller Artikelnummer: HY-P99033
• Alternativnummer: MCE-HY-P99033-1MG,MCE-HY-P99033-5MG,MCE-HY-P99033-10MG,MCE-HY-P99033-25MG,MCE-HY-P99033-50MG,MCE-HY-P99033-100MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: BTCT-4465A, RG-7828, RO7030816

Produktbeschreibung

Mosunetuzumab (BTCT-4465A) is a full-length, fully humanized immunoglobulin G1 (IgG1) T-cell-dependent bispecific (TDB) antibody targeting CD20 (B cells) and CD3 (T cells). Mosunetuzumab redirects T cells to engage and eliminate malignant B cells and can be used for the research of relapsed or refractory (R/R) B-cell non-Hodgkin lymphomas (B-NHLs)[1][2].

Produkteigenschaften

• Molekulargewicht: (144 kDa)
• Reinheit: 99.05
• CAS Nummer: [1905409-39-3]
• Target-Kategorie: CD20,CD3

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies